Header cover image

Australian (ASX) Clinical Research and Equipment Industry Analysis

UpdatedApr 13, 2024
DataAggregated Company Financials
Companies8
  • 7D3.8%
  • 3M21.3%
  • 1Y-13.0%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 4.2%, driven by gains from Trajan Group Holdings of 6.3%. During this same period, the Cryosite underperformed, falling 8.6%. In the past year, the industry is down 13%. Looking forward, earnings are forecast to grow by 76% annually.

Industry Valuation and Performance

Has the Australian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Apr 2024AU$594.3mAU$246.1m-AU$49,506,434.0015.1x-12x2.4x
Mon, 11 Mar 2024AU$552.6mAU$246.1m-AU$49,506,434.0012.8x-11.2x2.2x
Wed, 07 Feb 2024AU$484.4mAU$248.2m-AU$39,797,313.0025.1x-12.2x2x
Fri, 05 Jan 2024AU$446.7mAU$248.2m-AU$39,797,313.0021x-11.2x1.8x
Sun, 03 Dec 2023AU$569.5mAU$248.6m-AU$52,451,569.0019.1x-10.9x2.3x
Tue, 31 Oct 2023AU$556.8mAU$248.6m-AU$52,451,569.0022.5x-10.6x2.2x
Thu, 28 Sep 2023AU$534.0mAU$248.6m-AU$52,451,569.0022.5x-10.2x2.1x
Sat, 26 Aug 2023AU$605.5mAU$221.4m-AU$37,799,687.0022.5x-16x2.7x
Mon, 24 Jul 2023AU$670.4mAU$221.5m-AU$37,611,177.0025.2x-17.8x3x
Wed, 21 Jun 2023AU$643.3mAU$221.5m-AU$37,611,177.0024.4x-17.1x2.9x
Fri, 19 May 2023AU$614.7mAU$221.5m-AU$37,611,177.0028.7x-16.3x2.8x
Sun, 16 Apr 2023AU$691.1mAU$221.5m-AU$37,611,177.0028.3x-18.4x3.1x
Tue, 14 Mar 2023AU$765.9mAU$221.7m-AU$39,169,534.0029x-19.6x3.5x
Thu, 09 Feb 2023AU$807.0mAU$184.6m-AU$29,264,632.0031.6x-27.6x4.4x
Sat, 07 Jan 2023AU$792.8mAU$184.6m-AU$29,264,632.0034.7x-27.1x4.3x
Mon, 05 Dec 2022AU$766.3mAU$184.6m-AU$29,264,632.0034.3x-26.2x4.2x
Wed, 02 Nov 2022AU$761.7mAU$184.6m-AU$29,264,632.0026.6x-26x4.1x
Fri, 30 Sep 2022AU$781.2mAU$184.6m-AU$29,264,632.0030.4x-26.7x4.2x
Sun, 28 Aug 2022AU$894.5mAU$173.8m-AU$30,247,610.0049.7x-29.6x5.1x
Tue, 26 Jul 2022AU$900.0mAU$150.4m-AU$31,222,532.0027.4x-28.8x6x
Thu, 23 Jun 2022AU$790.5mAU$150.4m-AU$31,222,532.0027.2x-25.3x5.3x
Sat, 21 May 2022AU$1.0bAU$150.2m-AU$30,481,316.0026.3x-33.5x6.8x
Mon, 18 Apr 2022AU$1.2bAU$150.2m-AU$30,481,316.0020.8x-37.7x7.7x
Wed, 16 Mar 2022AU$1.1bAU$167.1m-AU$90,069,489.0019.1x-12.4x6.7x
Fri, 11 Feb 2022AU$1.5bAU$160.5m-AU$82,212,457.0071.7x-18.7x9.6x
Sun, 09 Jan 2022AU$1.7bAU$138.2m-AU$84,243,063.00135.7x-20.2x12.3x
Tue, 07 Dec 2021AU$1.3bAU$138.2m-AU$84,243,063.00103.5x-15.9x9.7x
Thu, 04 Nov 2021AU$1.4bAU$138.2m-AU$84,243,063.00109.2x-17x10.4x
Sat, 02 Oct 2021AU$1.5bAU$138.2m-AU$84,243,063.00114.1x-17.5x10.7x
Mon, 30 Aug 2021AU$1.5bAU$148.9m-AU$96,965,525.0096.9x-15x9.8x
Tue, 06 Jul 2021AU$1.4bAU$148.9m-AU$96,965,525.0063.2x-14.2x9.2x
Price to Earnings Ratio

-18.5x


Total Market Cap: AU$1.5bTotal Earnings: -AU$82,853,575.00Total Revenue: AU$78.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Clinical Research and Equipment Industry Price to Earnings3Y Average -19.2x202220232024
Current Industry PE
  • Investors are pessimistic on the Australian Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
  • Revenues for these companies have grown 46% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Australian Clinical Research and Equipment compare with similar industries?

AU Market0.16%
Healthcare-0.20%
Life Sciences3.79%
Clinical Research and Equipment3.79%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TRJ Trajan Group HoldingsAU$1.286.3%
+AU$11.4m
-25.0%PS1.2x
EZZ EZZ Life Science HoldingsAU$0.8423.5%
+AU$6.8m
97.6%PE10.3x
PIQ Proteomics International LaboratoriesAU$1.212.5%
+AU$3.9m
21.0%PS52.2x
GTG Genetic TechnologiesAU$0.1720.7%
+AU$3.5m
-50.0%PS2x
OSL OncoSil MedicalAU$0.00620.0%
+AU$2.3m
-42.9%PS10.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GTG

AU$0.17

Genetic Technologies

7D

20.7%

1Y

-50.0%

EZZ

AU$0.84

EZZ Life Science Holdings

7D

23.5%

1Y

97.6%

OSL

AU$0.006

OncoSil Medical

7D

20.0%

1Y

-42.9%

TRJ

AU$1.28

Trajan Group Holdings

7D

6.3%

1Y

-25.0%

CTE

AU$0.64

Cryosite

7D

-8.6%

1Y

-12.3%